Colinz Laboratories Ltd

Fri 4/09/2026,15:2:0 | BSE : COLINZ

₹72.561.06 (1.48%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 72.93

Previous Close

₹ 71.50

Volume

47

Mkt Cap ( ₹ Cr)

₹ 18.28

High

₹ 73.65

Low

₹ 72.56

52 Week High

₹ 87.91

52 Week Low

₹ 36.11

Book Value Per Share

₹ 49.40

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Colinz Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Colinz Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Colinz Laboratories - Post Offer Advertisement

    4 Sep 2026, 7:34PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of The

  • Colinz Laboratories - Reg. 34 (1) Annual Report.

    20 Aug 2026, 3:26PM Dear Sir,\r\n\r\nPursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for t

  • Colinz Laboratories - Notice Of Book Closure Under Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements), 2

    20 Aug 2026, 2:59PM Dear Sir,\r\n\r\nAS requied under Regulation 42 of SEBI(LODR) , Regulations, 2015 we are submitting herewith the Intimation towards closure of Book fr

  • Colinz Laboratories - Notice Of 40Th AGM And Book Closure.

    20 Aug 2026, 2:49PM As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submi

  • Colinz Laboratories - Updates on Open Offer

    12 Aug 2026, 6:19PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation

  • Colinz Laboratories - Updates on Open Offer

    6 Aug 2026, 6:04PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of offer opening public announcement under Regulation 18(7)

  • Colinz Laboratories - Letter of Offer

    31 Jul 2026, 6:03PM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Letter of Offer for the attention of the Public Sharehol

  • Colinz Laboratories - Outcome Of The Meeting Of Board Of Directors Was Held On Thursday, 30Th July, 2026 At 03:30 P.M. The Bo

    30 Jul 2026, 5:51PM Please find the attached OUTCOME of the meeting held today dated 30-07-2026 the details of the approved agenda are shown in the OUTCOME.

  • Colinz Laboratories - Board Meeting Outcome for OUTCOME Of The Meeting Of Board Of Directors Was Held On Thursday, 30Th July,

    30 Jul 2026, 5:42PM 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2026 as per Regulation 33 (3) of SEBI (Listing Obli

  • Colinz Laboratories - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR

    18 Jul 2026, 4:13PM Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider

  • Colinz Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    13 Jul 2026, 6:50PM As of June 2026, 50.60% is owned by Indian Promoters and 49.40% by Public. <p align=justify> Top five Promoters holding highest number of shares of Co

  • Colinz Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 4:23PM Dear Sir,\r\n\r\nPlease find the attached Certificate issued by our RTA Bigshare Services Pvt Ltd. for the Quarter ended on 30-6-2026 as required unde

  • Colinz Laboratories - Draft Letter of Offer

    4 Jul 2026, 8:24AM Saffron Capital Advisors Pvt Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Draft Letter of Offer (\DLOF\) for the attention of the

  • Colinz Laboratories - Certificate Of Non-Applicability Of Regulation 27(2) Of Chapter IV Of SEBI (Listing Obligation And Disc

    3 Jul 2026, 12:55PM Dear Sir,\r\n\r\nPlease find the attached Certificate from our PCA towards Non-Applicability of Corporate Governence as required under 15(2) of SEBI L

  • Colinz Laboratories - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviatio

    3 Jul 2026, 12:49PM Dear Sir,\r\n\r\nPlease find the attached Disclosure as required under Regulation 32 of SEBI (LODR), 2015 for the Quarter Ended on june-26. Kindly tak

  • Colinz Laboratories - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(

    3 Jul 2026, 12:44PM Please find the attached Disclosure towards NOn-Applicability of Related Party Transactions as per SEBI Regulation 23(9) for LODR, 2015. for the Quar

  • Colinz Laboratories - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2

    27 Jun 2026, 2:51PM Dear Sirs,\r\n\r\nThis has reference to the above captioned subject , we are submitting herewith the Discloure under Regulation 30 as amnded from time

  • Colinz Laboratories - Detailed Public Statement

    27 Jun 2026, 11:24AM Saffron Capital Advisors Private Limited (\Manager to the Offer\) has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1)

  • Colinz Laboratories - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    18 Jun 2026, 6:19PM Please the attached disclosure under regularion 30 and 30A of SEBI (LODR) Regulation 2015. towards Sales of Promoter Shares. The details informatiom i

  • Colinz Laboratories - Open Offer - Public Announcement

    18 Jun 2026, 5:13PM Saffron Capital Advisors Private Limited (\Manager to the Offer\) has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 ead

  • Colinz Laboratories - Clarification On Significant Movement In Share Price

    11 Jun 2026, 4:31PM This has reference to your mail asking clarification on 01-06-2026. Please find our reply and also clarification for significant movment in our share
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Colinz Laboratories Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 10.433 10.1153 9.5187 8.4126 8.1719
Liabilities 10.433 10.1153 9.5187 8.4126 8.1719
Equity 2.5191 2.5191 2.5191 2.5191 3.545
Gross Profit 0.4076 0.4951 0.5428 0.6089 0.5861
Net Profit 0.5145 0.4966 0.4867 0.4574 0.3393
Cash From Operating Activities 2.5411 -1.4537 1.0347 0.4029 0.4671
NPM(%) 8.38 7.6 6.92 6.39 4.86
Revenue 6.1361 6.5277 7.0296 7.1549 6.9742
Expenses 5.7285 6.0326 6.4868 6.546 6.3881
ROE(%) 4.13 3.99 3.91 3.67 2.72

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Colinz Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 863.00 -0.52 21.76 41.41 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.90 -0.68 1563.29 150.90 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.42 0.72 0.00 313.31 -39.50 0.00
Astec Lifesciences Ltd 552.30 -3.93 0.00 161.68 -363.14 0.00

Company Info

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Parent Organisation

Colinz Laboratories Ltd.

Founded

06/10/1986

Managing Director

NSE Symbol

FAQ